Patent details
LUC00209 Product Name: inclisiran
Basic Information
- Publication number:
- LUC00209
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP138113279
- Legal Status:
- Inactive
- Application number:
- LUC00209
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
- Marketing Authorization Number:
- EU/1/20/1494
- Marketing Authorization Type:
- Marketing Authorization Date:
- 10/12/2020
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Luxembourg (LU)
Dates
- Filing date:
- 04/06/2021
- First Marketing Authorization date:
- 10/12/2020
- Grant date:
- 07/10/2022
- Activation date:
- Publication date:
- 04/06/2021
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 10/12/2035
- SPC Extension Expiration:
- 10/12/2035
- Rejection date:
- Withdrawal date:
Owner
- From:
- 04/06/2021
- Name:
- Alnylam Pharmaceuticals, Inc.
- Address:
- 675 West Kendall Street Henri A. Termeer Square, MA 02142, Cambridge,, United States (US)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 04/06/2021
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Publication
Bulletin
1
- Bulletin Heading:
- SPC1
- Bulletin edition number:
- 2021/08
- Publication date:
- 01/07/2021
- Description:
- Section C : Published requests for Supplementary Protection Certificates – I1 publication
2
- Bulletin Heading:
- SPC2
- Bulletin edition number:
- 2022/12
- Publication date:
- 08/11/2022
- Description:
- Section D : Granted supplementary protection certificates – I2 publication
Annual Fees
- Annual Fee Due Date:
- 02/01/2034
- Annual Fee Number:
- 21
- Annual Fee Amount:
- 410 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|---|---|
| 04/06/2021 | Publication | 1 |
| 07/10/2022 | Publication | 1 |
| 10/10/2022 | Outgoing Correspondence | 1 |
| 07/10/2022 | Certificate | 1 |
| 04/06/2021 | Application Form | 3 |
| 04/06/2021 | Marketing authorization | 3 |
| 04/06/2021 | MA publication | 10 |
| 04/06/2021 | Outgoing Correspondence | 1 |
| 04/06/2021 | Summary of the product caracteristics | 30 |